Phase I/II Study Shows Promise for Melflufen in Multiple Myeloma

Researchers indicated that these results show the feasibility of this regimen and support the development of additional studies of melflufen in multiple myeloma, both in combination with dexamethasone as well as in triplet regimens.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Source Type: news